Subramaniam Ananthan

Also affiliated with BC Platforms (Finland)

NeuroscienceBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors”.

Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

Cancer Research(2021)10.1158/0008-5472.can-20-2858

N/A

0DataRank · unranked

32 citations

Xiuhua Yang, Subramaniam Ananthan, Jennifer Calano, Vibha Pathak, Larry Bratton +11 more

Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells

PLoS ONE(2021)10.1371/journal.pone.0250649

N/A

0DataRank · unranked

15 citations

Catherine Libby, Adetokunbo Ayokanmbi, Arphaxad Otamias, Juan Gordillo, Emily R. Gordon +9 more

SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice

Neuropharmacology(2022)10.1016/j.neuropharm.2022.109239

N/A

0DataRank · unranked

22 citations

Pamela M. Quizon, Yingying Wang, Charles Adeniran, Matthew J. Strauss, Ana Catya Jiménez-Torres +17 more

Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001291

N/A

0DataRank · unranked

9 citations

Mark J. Ferris, Subramaniam Ananthan, Corinne E. Augelli‐Szafran, Jun Zhu, Sarah E. Davis

SRI 22136, A Novel Delta Opioid Receptor (DOR) Antagonist for the Treatment of Alzheimer’s Disease

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r2776

N/A

0DataRank · unranked

0 citations

Subramaniam Ananthan, Vibha Pathak, Phanindra K. M. Venukadasula, Sixue Zhang, Omar Moukha Chafiq +3 more

Data from Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

(2023)10.1158/0008-5472.c.6513238.v1

N/A

0DataRank · unranked

0 citations

Xiuhua Yang, Subramaniam Ananthan, Jennifer Calano, Vibha Pathak, Larry Bratton +11 more

SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice

NeuroImmune Pharmacology and Therapeutics(2023)10.1515/nipt-2023-0022

N/A

0DataRank · unranked

0 citations

Shainnel O. Eans, Thomas J. Cirino, Subramaniam Ananthan, Ana Catya Jiménez-Torres, Jun Zhu +2 more

Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter

International Journal of Molecular Sciences(2024)10.3390/ijms25147881

N/A

0DataRank · unranked

5 citations

Katherine D. Porter, Jamison A. Hastie, Charles Adeniran, Omar Moukha‐Chafiq, Theresa Nguyen +5 more